Clinical Trial Update: Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

View source ↗

Summary

A postmarketing surveillance study of desvenlafaxine succinate (Pristiq) in Filipino patients with major depressive disorder and vasomotor symptoms; the study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Vasomotor Symptoms

Drugs mentioned

• Pristiq (Desvenlafaxine)

Snippet

Sponsor: Pfizer | Conditions: Major Depressive Disorder, Vasomotor Symptoms | Status: TERMINATED | Results posted: 2016-01-18